These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 23431627)

  • 1. [Factors linked to rapid progression to AIDS in Cuban subjects].
    Abrahantes Rodríguez Y; Pérez Avila J; Kouri Cardellá V; Fonseca Gómez C; Baly Gil A; Tápanes Fernandez T
    Rev Cubana Med Trop; 2010; 62(2):146-53. PubMed ID: 23431627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
    Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
    Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tuberculosis and AIDS: various clinical and epidemiological aspects in 72 Cuban patients].
    Reyes Corcho A; Díaz Jidy M; Pérez Rodríguez A
    Rev Cubana Med Trop; 2004; 56(1):35-41. PubMed ID: 15849907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS.
    Blattner WA; Oursler KA; Cleghorn F; Charurat M; Sill A; Bartholomew C; Jack N; O'Brien T; Edwards J; Tomaras G; Weinhold K; Greenberg M
    J Infect Dis; 2004 May; 189(10):1793-801. PubMed ID: 15122515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Change in the survival of Cuban AIDS patients with tuberculosis in the Highly Active Antiretroviral Therapy (HAART) era].
    Reyes-Corcho A; Capo de Paz V; Díaz-Jidy M; Pérez-Avila J; Bouza-Jiménez Y
    Invest Clin; 2008 Sep; 49(3):309-20. PubMed ID: 18846772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)].
    Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Iribarren JA; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P
    Enferm Infecc Microbiol Clin; 2000; 18(7):329-51. PubMed ID: 11109725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recommendations of GESIDA (Grupo de Estudio de SIDA)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (II)].
    Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Antonio Iribarren J; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P;
    Enferm Infecc Microbiol Clin; 2000 Oct; 18(8):396-412. PubMed ID: 11153204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rapid and slow progression of the infection by the type 1 human immunodeficiency virus in a population of seropositive subjects in Madrid].
    Soriano V; Martín R; del Romero J; Castilla J; Bru F; Bravo R; Gutiérrez M; Martínez P; Valencia E; García S; Mas A; Moreno V; Laguna F; Rodríguez C; Sabín ML; González-Lahoz J
    Med Clin (Barc); 1996 Dec; 107(20):761-6. PubMed ID: 9019602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
    Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
    N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
    Goujard C; Bonarek M; Meyer L; Bonnet F; Chaix ML; Deveau C; Sinet M; Galimand J; Delfraissy JF; Venet A; Rouzioux C; Morlat P;
    Clin Infect Dis; 2006 Mar; 42(5):709-15. PubMed ID: 16447119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
    Gandhi T; Wei W; Amin K; Kazanjian P
    Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progression and early predictors of AIDS in HIV-seroconverted injecting drug users. The Italian Seroconversion Study.
    AIDS; 1992 Apr; 6(4):421-6. PubMed ID: 1616637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
    Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH
    N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS).
    Farinpour R; Miller EN; Satz P; Selnes OA; Cohen BA; Becker JT; Skolasky RL; Visscher BR
    J Clin Exp Neuropsychol; 2003 Aug; 25(5):654-70. PubMed ID: 12815503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Discriminative value for AIDS case of erythrocyte sedimentation rate, immunoglobulins IgA and IgM, and beta 2-microglobulin in combination with the CD4+ lymphocyte count].
    Pérez de Oteyza C; Menéndez Martínez MA; Muro García R; Pérez Aznar C; Barberán López J
    An Med Interna; 1998 Aug; 15(8):411-4. PubMed ID: 9780421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of oral candidiasis as a marker of progression to AIDS.
    Fernández-Feijoo J; Diz-Dios P; Otero-Cepeda XL; Limeres-Posse J; de la Fuente-Aguado J; Ocampo-Hermida A
    Med Oral Patol Oral Cir Bucal; 2005; 10(1):36-40; 32-6. PubMed ID: 15627906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.